BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 33108543)

  • 1. Psychometric assessment of the PROMIS Fatigue Short Form 6a in women with moderate-to-severe endometriosis-associated pain.
    Pokrzywinski R; Soliman AM; Surrey E; Snabes MC; Coyne KS
    J Patient Rep Outcomes; 2020 Oct; 4(1):86. PubMed ID: 33108543
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of elagolix treatment on fatigue experienced by women with moderate to severe pain associated with endometriosis.
    Surrey ES; Soliman AM; Agarwal SK; Snabes MC; Diamond MP
    Fertil Steril; 2019 Aug; 112(2):298-304.e3. PubMed ID: 30992150
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Responsiveness and thresholds for clinically meaningful changes in worst pain numerical rating scale for dysmenorrhea and nonmenstrual pelvic pain in women with moderate to severe endometriosis.
    Pokrzywinski RM; Soliman AM; Snabes MC; Chen J; Taylor HS; Coyne KS
    Fertil Steril; 2021 Feb; 115(2):423-430. PubMed ID: 33066973
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reductions in endometriosis-associated pain among women treated with elagolix are consistent across a range of baseline characteristics reflective of real-world patients.
    Abrao MS; Surrey E; Gordon K; Snabes MC; Wang H; Ijacu H; Taylor HS
    BMC Womens Health; 2021 Jun; 21(1):246. PubMed ID: 34134684
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Achieving clinically meaningful response in endometriosis pain symptoms is associated with improvements in health-related quality of life and work productivity: analysis of 2 phase III clinical trials.
    Pokrzywinski RM; Soliman AM; Chen J; Snabes MC; Coyne KS; Surrey ES; Taylor HS
    Am J Obstet Gynecol; 2020 Jun; 222(6):592.e1-592.e10. PubMed ID: 31759891
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Psychometric properties of a custom Patient-Reported Outcomes Measurement Information System (PROMIS) physical function short form and worst stiffness numeric rating scale in tenosynovial giant cell tumors.
    Speck RM; Ye X; Bernthal NM; Gelhorn HL
    J Patient Rep Outcomes; 2020 Jul; 4(1):61. PubMed ID: 32676941
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Standardizing fatigue measurement in multiple sclerosis: the validity, responsiveness and score interpretation of the PROMIS SF v1.0 - Fatigue (MS) 8a.
    Kamudoni P; Johns J; Cook KF; Salem R; Salek S; Raab J; Middleton R; Henke C; Repovic P; Alschuler K; von Geldern G; Wundes A; Amtmann D
    Mult Scler Relat Disord; 2021 Sep; 54():103117. PubMed ID: 34256350
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment of Endometriosis-Associated Pain with Elagolix, an Oral GnRH Antagonist.
    Taylor HS; Giudice LC; Lessey BA; Abrao MS; Kotarski J; Archer DF; Diamond MP; Surrey E; Johnson NP; Watts NB; Gallagher JC; Simon JA; Carr BR; Dmowski WP; Leyland N; Rowan JP; Duan WR; Ng J; Schwefel B; Thomas JW; Jain RI; Chwalisz K
    N Engl J Med; 2017 Jul; 377(1):28-40. PubMed ID: 28525302
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinically Meaningful Reduction in Dyspareunia Is Associated With Significant Improvements in Health-Related Quality of Life Among Women With Moderate to Severe Pain Associated With Endometriosis: A Pooled Analysis of Two Phase III Trials of Elagolix.
    Agarwal SK; Soliman AM; Pokrzywinski RM; Snabes MC; Coyne KS
    J Sex Med; 2020 Dec; 17(12):2427-2433. PubMed ID: 32928659
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Endometriosis-Related Pain Reduction During Bleeding and Nonbleeding Days in Women Treated with Elagolix.
    Agarwal SK; Singh SS; Archer DF; Mai Y; Chwalisz K; Gordon K; Surrey E
    J Pain Res; 2021; 14():263-271. PubMed ID: 33564263
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Responsiveness Evaluation and Recommendation for Responder Thresholds for Endometriosis Health Profile-30: Analysis of Two Phase III Clinical Trials.
    Pokrzywinski R; Soliman AM; Chen J; Snabes MC; Taylor HS; Coyne KS
    J Womens Health (Larchmt); 2020 Feb; 29(2):253-261. PubMed ID: 31855102
    [No Abstract]   [Full Text] [Related]  

  • 12. A disease-specific measure of health-related quality of life in adults with chronic immune thrombocytopenic purpura: psychometric testing in an open-label clinical trial.
    Mathias SD; Bussel JB; George JN; McMillan R; Okano GJ; Nichol JL
    Clin Ther; 2007 May; 29(5):950-962. PubMed ID: 17697914
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Psychometric properties of the PROMIS
    Yang M; Keller S; Lin JS
    Qual Life Res; 2019 Dec; 28(12):3375-3384. PubMed ID: 31506915
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-Term Outcomes of Elagolix in Women With Endometriosis: Results From Two Extension Studies.
    Surrey E; Taylor HS; Giudice L; Lessey BA; Abrao MS; Archer DF; Diamond MP; Johnson NP; Watts NB; Gallagher JC; Simon JA; Carr BR; Dmowski WP; Leyland N; Singh SS; Rechberger T; Agarwal SK; Duan WR; Schwefel B; Thomas JW; Peloso PM; Ng J; Soliman AM; Chwalisz K
    Obstet Gynecol; 2018 Jul; 132(1):147-160. PubMed ID: 29889764
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reliability and Validity of Selected PROMIS Measures in People with Rheumatoid Arthritis.
    Bartlett SJ; Orbai AM; Duncan T; DeLeon E; Ruffing V; Clegg-Smith K; Bingham CO
    PLoS One; 2015; 10(9):e0138543. PubMed ID: 26379233
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Psychometric Evaluation of the Patient-Reported Outcomes Measurement Information System Fatigue-Short Form Across Diverse Populations.
    Ameringer S; Elswick RK; Menzies V; Robins JL; Starkweather A; Walter J; Gentry AE; Jallo N
    Nurs Res; 2016; 65(4):279-89. PubMed ID: 27362514
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reliability and validity of PROMIS physical function, pain interference, and fatigue as patient reported outcome measures in adult idiopathic inflammatory myopathies: International study from the OMERACT myositis working group.
    DiRenzo D; Saygin D; de Groot I; Bingham Iii CO; Lundberg IE; Needham M; Park JK; Regardt M; Sarver C; Song YW; Maxwell L; Beaton D; de Visser M; Christopher-Stine L; Mecoli CA; Alexanderson H
    Semin Arthritis Rheum; 2023 Feb; 58():152111. PubMed ID: 36410180
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of Endometriosis on Fatigue and Productivity Impairment in a Cross-Sectional Survey of Canadian Women.
    Soliman AM; Rahal Y; Robert C; Defoy I; Nisbet P; Leyland N; Singh S
    J Obstet Gynaecol Can; 2021 Jan; 43(1):10-18. PubMed ID: 32978082
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development and Validation of the Endometriosis Daily Pain Impact Diary Items to Assess Dysmenorrhea and Nonmenstrual Pelvic Pain.
    Wyrwich KW; O'Brien CF; Soliman AM; Chwalisz K
    Reprod Sci; 2018 Nov; 25(11):1567-1576. PubMed ID: 30033855
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Test-Retest Reliability and Responsiveness of PROMIS Sleep Short Forms Within an RCT in Women With Fibromyalgia.
    Chimenti RL; Rakel BA; Dailey DL; Vance CGT; Zimmerman MB; Geasland KM; Williams JM; Crofford LJ; Sluka KA
    Front Pain Res (Lausanne); 2021; 2():682072. PubMed ID: 35295526
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.